Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61 | 47 | 294 | 1,626 | 3,759 |
| TOTAL | $343 | $490 | $893 | $2,021 | $3,780 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 4 | 4 | 5 |
| Investments And Advances | 2 | 2 | 2 | 2 | 2 |
| Intangibles | 1,587 | 1,587 | 1,587 | 1,587 | 1,592 |
| Other Non-Current Assets | 19,400 | 19,400 | 19,465 | 19,400 | 19,400 |
| TOTAL | $20,991 | $20,992 | $21,058 | $20,993 | $21,000 |
| Total Assets | $21,335 | $21,482 | $21,950 | $23,014 | $24,779 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,863 | 986 | 909 | 309 | 367 |
| Accrued Expenses | 3,003 | 2,902 | 1,892 | 1,386 | 1,643 |
| Other current liabilities | 454 | 938 | 1,710 | 2,985 | 1,571 |
| TOTAL | $7,343 | $6,319 | $5,184 | $4,854 | $4,353 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,343 | $6,319 | $5,184 | $4,854 | $4,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 201 | 199 | 198 | 195 | 195 |
| Common Shares | 76 | 74 | 5 | 73 | 71 |
| Retained earnings | -22,256 | -19,512 | -17,336 | -14,747 | -11,131 |
| TOTAL | $13,992 | $15,164 | $16,766 | $18,160 | $20,426 |
| Total Liabilities And Equity | $21,335 | $21,482 | $21,950 | $23,014 | $24,779 |